CT0991
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CT0991, covering 2025-11-18 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]